Search
for

    Glossary Belimumab

    monoclonal antibody targeting B-lymphocyte stimulator for autoimmune conditions

    Belimumab is a monoclonal antibody that inhibits the activity of B-lymphocyte stimulator (BLyS), a protein involved in the survival and proliferation of B cells. It is primarily used in the treatment of systemic lupus erythematosus (SLE) but has gained attention for its potential role in hair loss conditions, particularly in cases of autoimmune-related alopecia. By modulating the immune response, belimumab may help reduce inflammation and promote hair regrowth in individuals experiencing hair loss due to autoimmune disorders. Its distinguishing characteristic is its targeted action on the immune system, differentiating it from other hair loss treatments that focus on hormonal or topical interventions.

    Sort by

    Research 30 of 61

    1. Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study Seminars in Arthritis and Rheumatism · 2018 · 70 citations
    2. AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort 2017 · 2 citations
    3. PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort Reumatismo · 2025
    4. PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort DOAJ (DOAJ: Directory of Open Access Journals) · 2025
    5. Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report American Journal of Case Reports · 2024
    6. POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS) 2024
    7. Alopecia areata after belimumab use in a patient with systemic lupus erythematosus: a paradoxical case of autoimmunity 2024
    8. FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study 2018
    9. The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket Immunosuppressives 2024
    10. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology · 2017 · 213 citations
    11. Pediatric Systemic Lupus Erythematosus: More Than a Positive Antinuclear Antibody Pediatrics in Review · 2012 · 54 citations
    12. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus JAMA Dermatology · 2017 · 16 citations
    13. Pediatric Systemic Lupus Erythematosus Pediatrics in Review · 2012 · 11 citations
    14. The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances Frontiers in Immunology · 2025 · 4 citations
    15. A case of simultaneous onset of highly active systemic lupus erythematosus and IgG4-related renal disease Modern Rheumatology Case Reports · 2022 · 3 citations
    16. ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT The Journal of Rheumatology · 2025 · 1 citations
    17. Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review Dermatology and Therapy · 2026
    18. New developments in the treatment of systemic lupus erythematosus Pediatric Nephrology · 2011 · 15 citations
    19. 2 SIDES OF LUPUS: CASE REPORT The Journal of Rheumatology · 2025 · 1 citations
    20. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management Expert Review of Clinical Immunology · 2012 · 87 citations
    21. A Case of Rhupus with Rowell Syndrome Open access rheumatology · 2020 · 3 citations
    22. Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance Frontiers in Medicine · 2026
    23. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    24. ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES The Journal of Rheumatology · 2025
    25. THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES The Journal of Rheumatology · 2025
    26. MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP The Journal of Rheumatology · 2025
    27. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    28. Skin involvement in systemic lupus erythematosus: a review article Revista română de reumatologie · 2023
    29. Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society Przegla̧d dermatologiczny · 2018
    30. Cutaneous Lupus Erythematosus Springer eBooks · 2017